CARDINAL HEALTH’S LEADERSHIP IN DEVELOPING THE CIRCULAR HEALTHCARE ECONOMY IN AUSTRALIAN MEDICAL DEVICES
With
Neroli Manning,
Managing Director
Cardinal Health – Australia & New Zealand
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | May 2026
Neroli Manning is the Managing Director for Cardinal Health Australia & New Zealand (ANZ). With over 30 years of experience in the healthcare industry, Neroli is a transformative leader known for her people-first, customer-centric leadership style.
Her career spans Australia, New Zealand, and the Asia Pacific region, where she has held senior management roles in the medical device, capital equipment, and radiopharmaceutical sectors with global leaders like CR Bard, Medtronic, Philips, Abbott, and Sirtex.
Neroli’s leadership is defined by her ability to drive change, foster collaboration, and build high-performing teams. Additionally, having held a variety of senior commercial functional positions, she is able to leverage her deep experience and cross-functional insights to align teams, streamline operations, and deliver strategic outcomes. She is also passionate about mentoring emerging leaders and shaping the future of healthcare through inclusive, values-driven leadership.
As a founder of her own healthcare consulting firm, Neroli demonstrated entrepreneurial leadership, guiding global medical device companies through complex market challenges. Her legacy includes cultivating cultures of accountability, innovation, and continuous learning.
Beyond leading Cardinal Health’s operations in ANZ, Neroli also contributes to the broader industry as a company director and member of the Industry Policy Committee for the Medical Technology Association of Australia (MTAA).
Neroli has a Master’s of Business (Marketing) degree from the University of Technology, Sydney. In her spare time, she enjoys spending time with friends and family, exercising, working on her farm, travelling and playing golf.
Source: Supplied
You Might also like
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Australian Healthcare and Hospitals Association Health Services and Systems Hospitals and Clinics New Content Patients
Professor Jeffrey Braithwaite on patient safety and health systems improvement
Professor Jeffrey Braithwaite is Founding Director of the Australian Institute of Health Innovation, Director of the Centre for Healthcare Resilience and Implementation Science and Professor of Health Systems Research at Macquarie University.
Professor Jeffrey Braithwaite is a leading health services and systems researcher with an international reputation for his work investigating and contributing to systems improvement.
The Australian Healthcare and Hospitals Association (AHHA) recently announced it will award the 2021 Sidney Sax medal for outstanding contributions to the development and improvement of Australia’s healthcare system to Professor Jeffrey Braithwaite.
-
Care workforce challenges
In a wide ranging report looking at the carer needs across Australia, PwC Australia published Reimagine Care Workforce Solutions in October 2022.
Australian Health Journal spoke with Kerryn Dillon, Director Ageing and Reablement and Health Workforce at PwC Australia about the community care sectors of aged care, disability care and childcare the report covers.